Alex Hartemink is part of a diverse Duke team to receive $5.9 million from the National Human Genome Research Institute to characterize how human lung epithelial cells respond to anti-inflammatory drugs called glucocorticoids. The team includes Medical School faculty members Tim Reddy and Greg Crawford, and the Pratt School's Charles Gersbach.
Department of Computer Science
